Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06597032 · ClinicalTrials.gov registry record · NA
The Resilience Challenge: Fostering Emotional Resilience During a Time of National Stress
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 11,659
- Enrollment target
NCT06597032: Completed NA study, sponsored by Northwestern University.
NCT06597032 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 11,659 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (731% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06597032, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,659 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to examine the effects of an online positive psychological intervention on positive emotion, anxiety, depression, feelings of social isolation, sleep disturbance and a sense of meaning and purpose in the general public. The main question it aims to answer is: Will the practice of positive emotion skills via a self-guided online platform reduce feelings of anxiety, depression, social isolation, and sleep disturbance, as well as increase well-being, positive emotion, a sense of meaning and purpose, life satisfaction, and general self-efficacy? Participants will take part in an online positive psychological skill learning intervention for 6-8 weeks. Prior to beginning, immediately after, and 4 weeks after, participants will fill out measures of their wellbeing.
Interventions
- BEHAVIORAL Resilience Challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,659 participants |
| Start Date | 2024-09-27 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
What the finished NCT06597032 record still lists
NCT06597032 is an interventional study that assigns participants to a tested intervention. Its 11,659 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (731% higher).
The record links to 0 conditions, and to 1 intervention - of which Resilience Challenge is the first listed.
NCT06597032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06597032 about?
NCT06597032 is a clinical study titled "The Resilience Challenge: Fostering Emotional Resilience During a Time of National Stress". The goal of this clinical trial is to examine the effects of an online positive psychological intervention on positive emotion, anxiety, depression, feelings of social isolation, sleep disturbance and a sense of meaning and purpose in the general public. The main question it aims to answer is: Will...
What is the current status of trial NCT06597032?
This trial is currently completed. It is a NA study. The enrollment target is 11,659 participants. The study started on 2024-09-27. Estimated completion is 2025-04-01.
What interventions are being tested in trial NCT06597032?
The interventions under investigation include: Resilience Challenge (BEHAVIORAL).
Who is sponsoring clinical trial NCT06597032?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06597032's enrollment target sits among peer trials
11,659 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07064473 · 11,800 participants · Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI